Stockreport

Arcus halts Gilead-partnered late-stage trial for lung cancer drug [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF of a late-stage trial designed to evaluate its anti-TIGIT therapy domvanalimab in lung cancer as part of a collaboration with Gilead Sciences ( Newsletters for Every I [Read more]